Diabetes Patients' Acceptance of Injectable Treatment, a Scientometric Analysis.
Ileana PanteaNadinne Alexandra RomanAngela RepanoviciDaniela DrugusPublished in: Life (Basel, Switzerland) (2022)
Diabetes is a condition associated with multiple systemic secondary risk factors, besides pancreatic dysfunctions, affecting the population worldwide and with high costs impacting the healthcare systems. This paper aims to identify the major issues in patients' adherence to injectable diabetes treatment. After the interrogation of the Web of Science database, a scientometric map was generated, from which six directions of approach were identified as essential factors influencing the patient's adherence. These directions yielded clusters of related articles. Glycemic control with the endocrinology metabolic implications, lifestyle adjustments, the healthcare services, medication therapy algorithm, healthcare services digitalization and healthcare policies seem to have a major impact on injectable diabetes therapy and patient adherence. Further research on every one of the six directions is needed to identify the potential of increasing injectable treatment adherence in diabetes patients.
Keyphrases
- glycemic control
- healthcare
- type diabetes
- end stage renal disease
- cardiovascular disease
- ejection fraction
- newly diagnosed
- risk factors
- chronic kidney disease
- blood glucose
- public health
- primary care
- physical activity
- machine learning
- mental health
- stem cells
- combination therapy
- adipose tissue
- adverse drug
- social media
- affordable care act